[Federal Register: November 27, 1998 (Volume 63, Number 228)]
[Notices]               
[Page 65602]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27no98-72]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of 
the National Cancer Advisory Board.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(6) and 552b(c)(9)(B), Title 5 
U.S.C. and section 10(d) of the Federal Advisory Committee Act, as 
amended, for discussions pertaining to NCI personnel and programmatic 
issues. These discussions could reveal information of a personal nature 
where disclosure would constitute a clearly unwarranted invasion of 
personal privacy and would be likely to significantly frustrate the 
subsequent implementation of personnel and programmatic recommendations 
made during these discussions.

    Name of Committe: National Cancer Advisory Board.
    Date: December 8-9, 1998.
    Open: December 8, 1998, 8:30 am to 4:00 pm and December 9, 1998, 
8:30 am to 1:00 pm.
    Agenda: Report of the Director, National Cancer Institute; 
Overview of Board of Scientific Advisors activities; Intramural and 
Extramural Program Overviews and Updates; Presentations by various 
NCI working groups on current and proposed program activities, 
projects and initiatives; other NCAB business.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Closed: December 8, 1998, 4:00 pm to 5:30 pm.
    Agenda: To review and evaluate discussion of Intramural site 
visits, proprietary, programmatic and personnel issues. Review and 
discussion of Extramural proprietary, programmatic and personnel 
issues.
    Place: National Cancer Institute, 9000 Rockville Pike, Building 
31, C Wing, 6th Floor, Conference Room 10, Bethesda, MD 20892.
    Contact Person: Dr. Marvin R. Kalt, Executive Secretary, 
Division of Extramural Activities, National Cancer Institute, 
National Institutes of Health, Executive Plaza North, Suite 600, 
6130 Executive Boulevard, Rockville, MD 20892, (301) 496-5147.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: November 19, 1998.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 98-31635 Filed 11-25-98; 8:45 am]
BILLING CODE 4140-01-M